Micro Cap Healthcare
Stocks Ranked by
Market Capitalization
Micro Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 492 micro cap Healthcare stocks — companies in the Healthcare sector with a market cap under $250M — worth a combined $31.4B.
The largest by market cap are Profound Medical (PROF) at $249M, Entrada Therapeutics (TRDA) at $249M and Fulcrum Therapeutics (FULC) at $246M.
Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.
- Combined market cap: $31.4B across 492 stocks.
- Micro Cap: market cap under $250M.
- Largest constituent: Profound Medical (PROF), $249M market cap.
- Most net new fund positions in Q1 2026: Atrium Therapeutics (RNA), +162 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.